
Sign up to save your podcasts
Or


In mid-2010, Bayer introduced a new, permanent contraceptive implant called Essure to the Australian pharmaceutical market. Eight years later, upon hearing reports that hundreds of women across Australia had suffered complications from the device, Slater and Gordon announced it would pursue a class action against Bayer.
On this episode of The Lawyers Weekly Show, Jerome Doraisamy is joined by Slater and Gordon associate Ebony Birchall to discuss this class action and reveal the outcome that claimants are hoping for.
www.lawyersweekly.com.au
By Momentum Media5
11 ratings
In mid-2010, Bayer introduced a new, permanent contraceptive implant called Essure to the Australian pharmaceutical market. Eight years later, upon hearing reports that hundreds of women across Australia had suffered complications from the device, Slater and Gordon announced it would pursue a class action against Bayer.
On this episode of The Lawyers Weekly Show, Jerome Doraisamy is joined by Slater and Gordon associate Ebony Birchall to discuss this class action and reveal the outcome that claimants are hoping for.
www.lawyersweekly.com.au

20 Listeners

613 Listeners

901 Listeners

20 Listeners

89 Listeners

325 Listeners

80 Listeners

394 Listeners

6 Listeners

16 Listeners

43 Listeners

35 Listeners

11 Listeners

22 Listeners

21 Listeners